Evidence map›Paper›PMID 28131861›Full record

ArticleToxicology2017

Alcoholic fatty liver is enhanced in CYP2A5 knockout mice: The role of the PPARα-FGF21 axis.

Xue Chen, Stephen C Ward, Arthur I Cederbaum, Huabao Xiong, Yongke Lu

Abstract read
In one paragraph

Article in Toxicology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 31 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Interaction between fatty acid oxidation and ethanol metabolism in liver.American journal of physiology. Gastrointestinal and liver physiology · 2024
    Review
  5. Article
  6. A Review: Cytochrome P450 in Alcoholic and Non-Alcoholic Fatty Liver Disease.Diabetes, metabolic syndrome and obesity : targets and therapy · 2024
    Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Nicotine enhances alcoholic fatty liver in mice: Role of CYP2A5.Archives of biochemistry and biophysics · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Xue ChenDepartment of Health Sciences, College of Public Health, East Tennessee State University, Johnson City, TN, United States.
Stephen C WardDepartment of Pathology, Icahn School of Medicine at Mount Sinai, New York, New York, United States.
Arthur I CederbaumDepartment of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, United States.
Huabao XiongDivision of Immunology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, United States.
Yongke LuDepartment of Health Sciences, College of Public Health, East Tennessee State University, Johnson City, TN, United States; Department of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, United States. Electronic address: luy004@etsu.edu.
Icahn School of Medicine at Mount Sinai · USEast Tennessee State University · US

Funding

Nicotine and Alcoholic Liver DiseaseR01AA024723 · NIAAA · MARSHALL UNIVERSITY · PI LU, YONGKE · 2016 to 2020
$1.8M
CYP2A5 and alcoholic liver diseaseR21AA020877 · NIAAA · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI LU, YONGKE · 2013 to 2014
$438k
NIAAA NIH HHS R01 AA024723NIAAA NIH HHS R21 AA020877
6 · The paper itself

Abstract

BACKGROUND &

aimsCytochrome P450 2A5 (CYP2A5) is induced by ethanol, and the ethanol induction of CYP2A5 is regulated by nuclear factor-erythroid 2-related factor 2 (NRF2). Cyp2a5 knockout (Cyp2a5

methodsMice were fed the Lieber-Decarli ethanol diet to induce alcoholic fatty liver.

resultsMore severe alcoholic fatty liver disease was developed in Cyp2a5

conclusionsThese results suggest that CYP2A5 protects against the development of alcoholic fatty liver disease, and the PPARα-FGF21 axis contributes to the protective effects of CYP2A5 on alcoholic fatty liver disease.

Indexed as

AnimalsAryl Hydrocarbon HydroxylasesCytochrome P450 Family 2Fatty Liver, AlcoholicFemaleFibroblast Growth FactorsMaleMiceMice, Inbred C57BLMice, KnockoutNF-E2-Related Factor 2PPAR alphaAryl Hydrocarbon HydroxylasesCyp2a5 protein, mouseCytochrome P450 Family 2fibroblast growth factor 21Fibroblast Growth FactorsNfe2l2 protein, mouseNF-E2-Related Factor 2PPAR alphaAlcoholic fatty liverCYP2A5FGF21PPARα

Identifiers

PMID28131861
PMCPMC5319905
OpenAlexW2582904160

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.